glp 1 receptors in brain GLP-1 receptor agonists effect on cognitive function patients with and without type 2 diabetes Distribution and characterisation of Glucagon-like

Tirzepatide has demonstrated unprecedented efficacy: in T2D trials (SURPASS program), the highest dose (15 mg) lowered HbA1c by ~2.02.5% on average and produced weight loss of 1012 kgpmc.ncbi.nlm.nih.gov

First identified in the 1970s, it is one of the more extensively studied peptides in the field of skin biology and tissue repair

however, this was for diabetes indications and GLP-1s were not included on the EML for obesity

Although some progress has been made in understanding the biological functions and potential mechanisms of the carnitine metabolism pool, their complexity and differences in pharmacology and pathophysiology still need to be further explored and understood

Anything that is severe, worsening, or systemic is a reason to stop and seek a clinician rather than to adjust the protocol